Cwm LLC boosted its stake in HCA Healthcare, Inc. (NYSE:HCA – Free Report) by 4.3% in the 3rd quarter, according to its most recent filing with the SEC. The fund owned 10,288 shares of the company’s stock after purchasing an additional 421 shares during the period. Cwm LLC’s holdings in HCA Healthcare were worth $4,181,000 at the end of the most recent quarter.
Several other institutional investors and hedge funds have also recently modified their holdings of the company. Bangor Savings Bank boosted its stake in shares of HCA Healthcare by 112.5% in the second quarter. Bangor Savings Bank now owns 85 shares of the company’s stock valued at $27,000 after purchasing an additional 45 shares during the period. MFA Wealth Advisors LLC purchased a new stake in shares of HCA Healthcare during the second quarter worth $27,000. Unique Wealth Strategies LLC acquired a new position in HCA Healthcare during the 2nd quarter worth $28,000. GPS Wealth Strategies Group LLC raised its position in HCA Healthcare by 284.0% in the 2nd quarter. GPS Wealth Strategies Group LLC now owns 96 shares of the company’s stock valued at $31,000 after purchasing an additional 71 shares in the last quarter. Finally, Benjamin F. Edwards & Company Inc. purchased a new stake in shares of HCA Healthcare during the second quarter worth approximately $33,000. Hedge funds and other institutional investors own 62.73% of the company’s stock.
Insider Buying and Selling
In other news, EVP Michael S. Cuffe sold 8,358 shares of the stock in a transaction dated Thursday, September 12th. The shares were sold at an average price of $385.42, for a total transaction of $3,221,340.36. Following the transaction, the executive vice president now directly owns 29,678 shares in the company, valued at $11,438,494.76. This represents a 0.00 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available at this link. In other news, EVP Michael S. Cuffe sold 8,358 shares of the company’s stock in a transaction on Thursday, September 12th. The stock was sold at an average price of $385.42, for a total transaction of $3,221,340.36. Following the completion of the sale, the executive vice president now directly owns 29,678 shares in the company, valued at $11,438,494.76. This represents a 0.00 % decrease in their position. The transaction was disclosed in a filing with the SEC, which is available at this link. Also, SVP Kathryn A. Torres sold 1,857 shares of the business’s stock in a transaction dated Thursday, July 25th. The shares were sold at an average price of $355.05, for a total value of $659,327.85. Following the sale, the senior vice president now directly owns 17,755 shares of the company’s stock, valued at approximately $6,303,912.75. This trade represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 17,202 shares of company stock worth $6,407,273. 1.60% of the stock is owned by company insiders.
HCA Healthcare Stock Up 1.9 %
HCA Healthcare (NYSE:HCA – Get Free Report) last issued its quarterly earnings data on Tuesday, July 23rd. The company reported $5.50 EPS for the quarter, beating analysts’ consensus estimates of $4.97 by $0.53. The firm had revenue of $17.49 billion for the quarter, compared to analysts’ expectations of $17.05 billion. HCA Healthcare had a net margin of 8.40% and a return on equity of 553.13%. The firm’s revenue was up 10.3% on a year-over-year basis. During the same period in the prior year, the company earned $4.29 EPS. On average, equities analysts anticipate that HCA Healthcare, Inc. will post 22.51 earnings per share for the current fiscal year.
HCA Healthcare Dividend Announcement
The firm also recently disclosed a quarterly dividend, which was paid on Monday, September 30th. Stockholders of record on Monday, September 16th were given a $0.66 dividend. This represents a $2.64 dividend on an annualized basis and a dividend yield of 0.67%. The ex-dividend date of this dividend was Monday, September 16th. HCA Healthcare’s dividend payout ratio is currently 13.16%.
Analysts Set New Price Targets
A number of equities research analysts have commented on HCA shares. Wolfe Research raised shares of HCA Healthcare to a “strong-buy” rating in a research report on Thursday, August 29th. Royal Bank of Canada increased their price target on shares of HCA Healthcare from $378.00 to $405.00 and gave the company an “outperform” rating in a research note on Friday, August 23rd. Truist Financial upped their target price on shares of HCA Healthcare from $390.00 to $430.00 and gave the company a “buy” rating in a report on Monday, August 19th. UBS Group upped their price objective on shares of HCA Healthcare from $405.00 to $438.00 and gave the company a “buy” rating in a research note on Wednesday, August 14th. Finally, Deutsche Bank Aktiengesellschaft boosted their target price on HCA Healthcare from $359.00 to $375.00 and gave the company a “buy” rating in a report on Friday, June 28th. Five research analysts have rated the stock with a hold rating, fourteen have assigned a buy rating and four have issued a strong buy rating to the stock. Based on data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and an average target price of $365.65.
Read Our Latest Stock Analysis on HCA
About HCA Healthcare
HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.
Recommended Stories
- Five stocks we like better than HCA Healthcare
- What is the Australian Securities Exchange (ASX)
- 3 Mid-Cap Stocks Under $20 With Insider Buying and Major Upside
- Investing in Commodities: What Are They? How to Invest in Them
- China’s EV Rally: Should Investors Chase, Avoid, or Buy the Dip?
- How to Invest in Blue Chip Stocks
- MarketBeat Week in Review – 10/7 – 10/11
Want to see what other hedge funds are holding HCA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HCA Healthcare, Inc. (NYSE:HCA – Free Report).
Receive News & Ratings for HCA Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.